Condition protocol · 6 min read

Post-concussion syndrome supplement protocol — what the evidence supports

Updated 2026-05-18 · Reviewed by SupplementScore editors · No sponsorships

Concussion (mild traumatic brain injury, mTBI) typically resolves within 2–4 weeks. When symptoms persist — headache, fatigue, cognitive fog, sleep disturbance, mood changes, balance and vestibular dysfunction — beyond 4 weeks, the picture is called persistent post-concussion symptoms (PPCS) or post-concussion syndrome. Management is multimodal: graded sub-symptom-threshold aerobic exercise, vestibular and oculomotor rehabilitation, cognitive rest pacing, sleep restoration, treatment of comorbid headache and mood symptoms. The supplement layer is supportive: high-dose omega-3 (animal and case-series data), creatine (neurometabolic rationale and small TBI trials), magnesium (cofactor and migraine-prevention extension), and CoQ10 (mitochondrial support).

Read this first. Concussion is a clinical diagnosis. Red flags after any head injury — worsening headache, repeated vomiting, seizure, weakness, severe drowsiness, focal neurologic signs, slurred speech, coagulation impairment, or anticoagulant use — require urgent emergency evaluation including imaging. Persistent symptoms beyond 4 weeks deserve evaluation by a clinician familiar with concussion (sports medicine, neurology, physiatry) for structured graded-exertion testing, vestibular and oculomotor assessment, and consideration of cervicogenic and visual contributions. Supplements are adjuncts — they do not replace structured rehabilitation.

What actually has trial or mechanistic support

Tier 2 evidence · Case series, dose-response signal

Omega-3 (high-dose EPA/DHA)

3–4 g EPA+DHA/day with a fat-containing meal; start within days of injury when possible

Pre-clinical and case-series evidence support high-dose omega-3 as a neuroprotective adjunct in concussion and TBI. The mechanism involves reduced neuroinflammation, support of membrane lipid repair, and modulation of apoptotic cascades. Trials have used substantially higher doses than typical (3–4 g/day) for the first weeks post-injury. Discuss with prescriber if on anticoagulants. The 4 g/day pharmaceutical EPA atrial-fibrillation signal is documented in cardiology cohorts; relevant if patient has arrhythmia history.

Tier 2 evidence · Small TBI trials

Creatine monohydrate

5 g/day continuously; or pediatric protocol 0.4 g/kg/day

Creatine's neurometabolic rationale in concussion (ATP buffering, mitochondrial support, reduced oxidative stress) is supported by both pre-clinical and small pediatric TBI trials (Sakellaris). Adult PPCS trials are smaller but consistent with a mild-to-moderate benefit on cognitive symptoms and fatigue. Safe for long-term use; the dose-time-to-effect is 3–4 weeks to muscle and brain saturation.

Tier 2 evidence · Migraine extension

Magnesium glycinate

400 mg elemental at bedtime

Concussion frequently produces a migraine-pattern headache (post-traumatic migraine), and magnesium has Level B evidence in migraine prevention generally. Magnesium also addresses cofactor needs in vitamin D metabolism, NMDA-glutamate excitation, and sleep regulation — all relevant to concussion recovery.

Tier 3 evidence · Mitochondrial adjunct

CoQ10 (ubiquinol)

100 mg t.i.d. (300 mg/day total)

Concussion alters cerebral mitochondrial function. CoQ10 has Level B evidence in migraine and is reasonable in PPCS particularly when post-traumatic headache, fatigue, and exertional intolerance dominate. Pair with magnesium and riboflavin for the full headache-prevention layer.

Tier 3 evidence · Headache stack adjunct

Riboflavin (vitamin B2)

400 mg in the morning with food

Level B AAN evidence in migraine; reasonable in post-traumatic migraine phenotype. Bright yellow urine is harmless and indicates absorption.

Tier 3 evidence · Sleep restoration

Melatonin (sleep restoration)

0.3–3 mg 30–60 minutes before desired sleep onset

Sleep disturbance is one of the most consistent post-concussion symptoms and one of the strongest predictors of slow recovery. Low-dose melatonin restores sleep architecture in many post-concussion patients; some pediatric and adolescent concussion trials support its use.

The rehabilitation base — far higher yield than supplements

These interventions have higher-quality outcomes evidence than any supplement and should anchor recovery:

Graded sub-symptom-threshold aerobic exercise — Buffalo Concussion Treadmill Test-guided rehabilitation reduces recovery time meaningfully; the era of prolonged "cocoon" rest is over.
Vestibular and oculomotor rehabilitation — for dizziness, balance issues, screen intolerance, gaze stabilisation.
Cervicogenic assessment and treatment — whiplash-overlap is common and often missed; manual therapy and targeted exercises help.
Sleep restoration — consistent wake time, dark room, screen-reduction past sunset; consider short-term melatonin.
Symptom pacing, not avoidance — gradually build cognitive and physical loads back; complete avoidance prolongs recovery.
Headache-specific treatment — post-traumatic migraine often responds to standard migraine prevention strategies.
Mental health support — anxiety and low mood are common and worsen recovery; CBT and treatment of comorbid depression matter.
Return-to-learn / return-to-play protocols — graded staged progression with clear stopping criteria.

What to skip

"Brain repair" megadose multivitamins with 50+ ingredients — no targeted evidence; risk of vitamin A excess and other megadose problems.
Hyperbaric oxygen for routine PPCS — trials are mixed; not first-line; expensive.
High-dose vitamin E (above 400 IU/day) — older TBI data; mortality signal at very high doses in other contexts.
Megadose curcumin without bioavailability formulation — bioavailability is the rate-limit; spend money on phytosome/BCM-95.
Stimulants (caffeine megadoses) to push through symptoms — masks recovery feedback and delays healing.
Cannabis and CBD products marketed for concussion recovery — limited quality evidence; some products may worsen cognitive symptoms.
Nootropic stacks (racetams, modafinil for OTC use, etc.) — not evidence-based in concussion; can mask symptoms.
Heavy NSAID use long-term — risk of medication overuse headache; complicates the post-traumatic migraine picture.

What to track

Use a validated symptom inventory — the Sport Concussion Assessment Tool (SCAT) symptom list, the Rivermead Post-Concussion Symptoms Questionnaire, or the Post-Concussion Symptom Scale. Score weekly. Track sleep duration and quality. Document exercise tolerance via the Buffalo Concussion Treadmill Test when supervised. Recovery is non-linear and patient — most concussions resolve within 4 weeks, persistent symptoms typically improve over 3–6 months with appropriate rehabilitation, and a minority require longer specialist care.

Practical quick-start. Anchor recovery to graded sub-symptom-threshold aerobic exercise + vestibular/oculomotor rehabilitation + sleep restoration under supervision of a concussion-experienced clinician. As supplement adjuncts: omega-3 (EPA+DHA) 3 g/day with food (discuss with prescriber if on anticoagulants), creatine monohydrate 5 g/day, magnesium glycinate 400 mg at bedtime, riboflavin 400 mg with breakfast, CoQ10 ubiquinol 100 mg t.i.d. if post-traumatic headache and fatigue are dominant. Low-dose melatonin 0.3–1 mg at sleep onset if sleep is disrupted. Track symptom scores weekly. Escalate if symptoms worsen, change character, or fail to improve by 8 weeks.